Free Trial

Teachers Retirement System of The State of Kentucky Has $6.37 Million Stock Position in Tempus AI, Inc. (NASDAQ:TEM)

Tempus AI logo with Medical background

Teachers Retirement System of The State of Kentucky lifted its position in Tempus AI, Inc. (NASDAQ:TEM - Free Report) by 4.3% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 132,000 shares of the company's stock after buying an additional 5,500 shares during the quarter. Teachers Retirement System of The State of Kentucky owned about 0.08% of Tempus AI worth $6,368,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors and hedge funds have also modified their holdings of the company. Sumitomo Mitsui Trust Group Inc. raised its stake in Tempus AI by 31.4% during the 1st quarter. Sumitomo Mitsui Trust Group Inc. now owns 4,255,477 shares of the company's stock valued at $205,284,000 after purchasing an additional 1,016,384 shares during the last quarter. Franklin Resources Inc. raised its stake in Tempus AI by 240.5% during the 4th quarter. Franklin Resources Inc. now owns 2,762,173 shares of the company's stock valued at $93,251,000 after purchasing an additional 1,950,862 shares during the last quarter. JPMorgan Chase & Co. raised its stake in Tempus AI by 86,947.2% during the 4th quarter. JPMorgan Chase & Co. now owns 1,653,896 shares of the company's stock valued at $55,836,000 after purchasing an additional 1,651,996 shares during the last quarter. Norges Bank acquired a new position in Tempus AI during the 4th quarter valued at $34,681,000. Finally, Alliancebernstein L.P. raised its stake in Tempus AI by 40.3% during the 4th quarter. Alliancebernstein L.P. now owns 945,133 shares of the company's stock valued at $31,908,000 after purchasing an additional 271,591 shares during the last quarter. 24.22% of the stock is currently owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Eric P. Lefkofsky sold 250,000 shares of the stock in a transaction that occurred on Tuesday, June 17th. The stock was sold at an average price of $70.07, for a total transaction of $17,517,500.00. Following the completion of the sale, the chief executive officer directly owned 9,357,283 shares of the company's stock, valued at approximately $655,664,819.81. This represents a 2.60% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, EVP Erik Phelps sold 51,317 shares of the stock in a transaction that occurred on Monday, June 16th. The stock was sold at an average price of $72.56, for a total value of $3,723,561.52. Following the sale, the executive vice president directly owned 97,779 shares of the company's stock, valued at approximately $7,094,844.24. The trade was a 34.42% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 612,522 shares of company stock worth $41,600,238 over the last ninety days. Company insiders own 27.60% of the company's stock.

Tempus AI Stock Down 4.9%

Shares of NASDAQ:TEM opened at $58.01 on Tuesday. The company has a quick ratio of 1.56, a current ratio of 1.71 and a debt-to-equity ratio of 2.45. Tempus AI, Inc. has a 12 month low of $31.36 and a 12 month high of $91.45. The firm has a market cap of $10.04 billion and a P/E ratio of -7.44. The company's 50-day moving average price is $63.06 and its two-hundred day moving average price is $55.95.

Tempus AI (NASDAQ:TEM - Get Free Report) last released its earnings results on Tuesday, May 6th. The company reported ($0.24) earnings per share (EPS) for the quarter, beating analysts' consensus estimates of ($0.27) by $0.03. Tempus AI had a negative net margin of 88.27% and a negative return on equity of 533.21%. The company had revenue of $255.74 million for the quarter, compared to the consensus estimate of $248.13 million. Tempus AI's revenue was up 75.4% on a year-over-year basis. As a group, research analysts forecast that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

Several equities research analysts have issued reports on TEM shares. Bank of America boosted their price target on shares of Tempus AI from $68.00 to $70.00 and gave the company a "neutral" rating in a report on Wednesday, June 25th. Morgan Stanley boosted their price target on shares of Tempus AI from $60.00 to $65.00 and gave the company an "overweight" rating in a report on Friday, May 9th. Guggenheim boosted their price target on shares of Tempus AI from $65.00 to $75.00 and gave the company a "buy" rating in a report on Monday, June 30th. BTIG Research started coverage on shares of Tempus AI in a report on Monday, April 21st. They issued a "buy" rating and a $60.00 price target on the stock. Finally, Piper Sandler upped their target price on shares of Tempus AI from $55.00 to $70.00 and gave the stock a "neutral" rating in a report on Thursday, May 15th. Six equities research analysts have rated the stock with a hold rating and six have given a buy rating to the company. According to data from MarketBeat.com, the stock presently has an average rating of "Moderate Buy" and a consensus target price of $65.09.

View Our Latest Stock Analysis on Tempus AI

Tempus AI Company Profile

(Free Report)

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.

Featured Articles

Institutional Ownership by Quarter for Tempus AI (NASDAQ:TEM)

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Tempus AI Right Now?

Before you consider Tempus AI, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Tempus AI wasn't on the list.

While Tempus AI currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

7 Stocks to Buy And Hold Forever Cover

Enter your email address and we'll send you MarketBeat's list of seven stocks and why their long-term outlooks are very promising.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

Why Drone Stocks Are Skyrocketing Right Now!
Pelosi Makes Big Bet on Broadcom—Here’s Why It Matters
This Strategy Beat the S&P—And Most Investors Ignore It

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines